AOD 9604 5MG

AOD 9604

AOD 9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH). It has been extensively researched for its potential effects on fat metabolism, lipolysis, and weight regulation, without stimulating systemic growth hormone activity. AOD 9604 is a valuable research tool in metabolic studies, obesity research, and adipose tissue biology.

Research on AOD 9604 focuses on its ability to regulate lipid metabolism, enhance fat breakdown, and influence adipocyte function without affecting blood glucose levels or insulin sensitivity. It is widely investigated in experimental models for its potential anti-obesity and metabolic regulatory effects.

Overview

AOD 9604 mimics the lipolytic domain of human growth hormone, targeting fat metabolism pathways. Unlike full-length growth hormone, AOD 9604 does not stimulate IGF-1 production or systemic anabolic effects, making it a safer model for studying fat reduction mechanisms. The peptide promotes triglyceride breakdown, increases fatty acid oxidation, and supports overall lipid homeostasis in experimental settings.

Through these mechanisms, AOD 9604 is a valuable compound for research on obesity, metabolic syndrome, lipid regulation, and adipose tissue biology.

• Promotes fat metabolism and triglyceride breakdown
• Enhances fatty acid oxidation without systemic growth hormone stimulation
• Supports adipocyte regulation and lipid homeostasis
• Investigated in obesity, metabolic syndrome, and lipid biology research
• Non-anabolic, does not stimulate IGF-1 production or insulin dysregulation

Specifications

• Peptide Type: hGH-derived fragment (C-terminal amino acids 177–191)
• Amino Acid Length: 15 amino acids
• Molecular Formula: C₇₆H₁₂₃N₂₃O₂₃S
• Molecular Weight: ~1663 Da
• Other Names: AOD-9604, HGH Fragment 177–191, Anti-Obesity Peptide

Research and Clinical Insights

Lipolytic and Metabolic Effects

AOD 9604 has been shown in experimental studies to stimulate lipolysis in adipose tissue, enhance fatty acid oxidation, and improve overall lipid metabolism. It is actively used in models investigating weight management and obesity-related metabolic pathways.

Adipose Tissue Regulation

The peptide modulates adipocyte function, promoting lipid turnover while preserving muscle tissue. Research indicates that AOD 9604 selectively targets fat cells without producing systemic anabolic effects associated with growth hormone therapy.

Safety and Non-Anabolic Properties

Unlike full-length human growth hormone, AOD 9604 does not increase IGF-1 levels or interfere with glucose metabolism. This property makes it a safe research model for studying fat metabolism without confounding systemic growth hormone effects.

Applications in Obesity and Metabolic Research

AOD 9604 is widely used in preclinical studies to explore anti-obesity interventions, metabolic syndrome treatments, and adipose tissue modulation. It provides a reliable model for evaluating novel therapies targeting fat reduction and metabolic regulation.

Usage Considerations

AOD 9604 is supplied strictly for research and laboratory use. It is not approved for human therapeutic application. All handling, storage, and experimental procedures must comply with institutional safety standards and regulatory guidelines.

Notice: AOD 9604 is provided for research purposes only. Please review and adhere to all Terms and Conditions prior to ordering.